Critical Therapeutics Inc (fka CRTX)

[McMagyar]

Tempe
Here is the question I ask..

Slowing the decline by 50% would have been great 10 years ago..
Would have killed it..
destroyed Memantine and other fake AD
Drug ( which I can’t remember- guess why)

But here we are now..

So this drug fails because I’m this order
Other deugs will render it to the sideline..
Anavex, Cassava, Annovis..

All three will clinically kick it’s ass..

Hindsight 20/20.. here we are..

Strategically right now WE know this drug at high dose can help millions of people right now that signal high expression of target..( again can’t remember name of target.. dimentia sucks ass)
BUT since that was NOT goal of Trial or endpoint..
the FDA is Most likely going to continue feeding the memory care institution with human cattle.. right?

Can’t fight the FDA.. can you ???




None of these bastards are making this Human!!!

Where are the people that reduced less ??
Put them on camera.. let them beg for access to the country.. do something!!

Anavex (80% save) will be here in less than a year..maybe it will work even better with those expressing ……
Cassava (8x% success) will be here in 2 years..
Annnovis maybe three..

This drug could act as adjuvant for one or maybe all three.. reducing those who express that signal..


So the DRUG has value..

Is there a type of dementia wherein this over expression is more greatly exhibited?
The test for the expression is easy inexpensive?

I don’t know where the MC value shoul be ,, but we do have to quit throwing away drugs that show a targeted success because not everyone got better..

Wasn’t there a nicotine targeted drug that did well but screwed up their Endpoint so it failed?


Yes Biogen’s blain dweller rocks it out of FDA because the right advocates were on board.. $$$ talks .. even when it’s your parents.. we suck